Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice

References (1)

1. Agarwal SK, Agarwal S. Role of Intracoronary Fibrinolytic Therapy in Contemporary PCI Practice. Cardiovasc Revasc Med 2019; 20: 1165-71. [Crossref] 2. Doğan Ö, Barman HA, Gökçe ME, Dönmez A, Ersanlı MK. A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor. Anatol J Cardiol 2021; 25: 352-4. [Crossref] 3. Harada M, Akimoto K, Otaka M, Sato K, Oda H, Otsuki M, et al. Thrombolytic therapy in Kawasaki disease: a report of four cases. Pediatr Int 2013; 55: e111-5. [Crossref] 4. Yao SS, Spindola-Franco H, Menegus M, Greenberg M, Goldberger M, Shirani J. Successful intracoronary thrombolysis in cocaineassociated acute myocardial infarction. Cathet Cardiovasc Diagn 1997; 42: 294-7. 5. Gurbel PA, Navetta FI, Bates ER, Muller DW, Tenaglia AN, Miller MJ, et al. Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn 1996; 37: 382-91.